vs
Matador Resources Co（MTDR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Matador Resources Co的季度营收约是Royalty Pharma plc的1.3倍（$809.5M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 23.8%，领先10.7%），Royalty Pharma plc同比增速更快（4.8% vs -17.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.5%）
Matador Resources Co是一家独立能源企业，主营石油、天然气及天然气凝液的勘探、开发、生产与收购业务，核心运营区域分布在美国多个主要陆上资源盆地，产品主要供应北美能源市场。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MTDR vs RPRX — 直观对比
营收规模更大
MTDR
是对方的1.3倍
$622.0M
营收增速更快
RPRX
高出22.0%
-17.2%
净利率更高
RPRX
高出10.7%
23.8%
两年增速更快
RPRX
近两年复合增速
1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $809.5M | $622.0M |
| 净利润 | $192.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 30.0% | 62.4% |
| 净利率 | 23.8% | 34.4% |
| 营收同比 | -17.2% | 4.8% |
| 净利润同比 | -10.2% | 2.9% |
| 每股收益（稀释后） | $1.54 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTDRRPRX
| Q4 25 | $809.5M | $622.0M | ||
| Q3 25 | $915.1M | $609.3M | ||
| Q2 25 | $925.7M | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $978.3M | $593.6M | ||
| Q3 24 | $860.1M | $564.7M | ||
| Q2 24 | $855.2M | $537.3M | ||
| Q1 24 | $785.3M | $568.0M |
净利润MTDRRPRX
| Q4 25 | $192.5M | $214.2M | ||
| Q3 25 | $176.4M | $288.2M | ||
| Q2 25 | $150.2M | $30.2M | ||
| Q1 25 | $240.1M | $238.3M | ||
| Q4 24 | $214.5M | $208.2M | ||
| Q3 24 | $248.3M | $544.0M | ||
| Q2 24 | $228.8M | $102.0M | ||
| Q1 24 | $193.7M | $4.8M |
营业利润率MTDRRPRX
| Q4 25 | 30.0% | 62.4% | ||
| Q3 25 | 33.4% | 70.1% | ||
| Q2 25 | 31.2% | 36.3% | ||
| Q1 25 | 38.7% | 94.0% | ||
| Q4 24 | 36.8% | 60.9% | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 42.5% | 50.2% | ||
| Q1 24 | 40.6% | -13.0% |
净利率MTDRRPRX
| Q4 25 | 23.8% | 34.4% | ||
| Q3 25 | 19.3% | 47.3% | ||
| Q2 25 | 16.2% | 5.2% | ||
| Q1 25 | 23.9% | 41.9% | ||
| Q4 24 | 21.9% | 35.1% | ||
| Q3 24 | 28.9% | 96.3% | ||
| Q2 24 | 26.8% | 19.0% | ||
| Q1 24 | 24.7% | 0.8% |
每股收益（稀释后）MTDRRPRX
| Q4 25 | $1.54 | $0.49 | ||
| Q3 25 | $1.42 | $0.67 | ||
| Q2 25 | $1.21 | $0.07 | ||
| Q1 25 | $1.92 | $0.55 | ||
| Q4 24 | $1.71 | $0.46 | ||
| Q3 24 | $1.99 | $1.21 | ||
| Q2 24 | $1.83 | $0.23 | ||
| Q1 24 | $1.61 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.3M | $618.7M |
| 总债务越低越好 | $3.4B | $9.0B |
| 股东权益账面价值 | $5.7B | $9.7B |
| 总资产 | $11.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.60× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MTDRRPRX
| Q4 25 | $15.3M | $618.7M | ||
| Q3 25 | $20.1M | $938.9M | ||
| Q2 25 | $10.5M | $631.9M | ||
| Q1 25 | $14.5M | $1.1B | ||
| Q4 24 | $23.0M | $929.0M | ||
| Q3 24 | $23.3M | $950.1M | ||
| Q2 24 | $15.2M | $1.8B | ||
| Q1 24 | $23.2M | $843.0M |
总债务MTDRRPRX
| Q4 25 | $3.4B | $9.0B | ||
| Q3 25 | $3.2B | $8.9B | ||
| Q2 25 | $3.3B | $8.0B | ||
| Q1 25 | $3.2B | $7.6B | ||
| Q4 24 | $3.3B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MTDRRPRX
| Q4 25 | $5.7B | $9.7B | ||
| Q3 25 | $5.5B | $9.6B | ||
| Q2 25 | $5.4B | $9.5B | ||
| Q1 25 | $5.3B | $9.8B | ||
| Q4 24 | $5.1B | $10.3B | ||
| Q3 24 | $4.9B | $10.3B | ||
| Q2 24 | $4.6B | $9.8B | ||
| Q1 24 | $4.4B | $9.9B |
总资产MTDRRPRX
| Q4 25 | $11.7B | $19.6B | ||
| Q3 25 | $11.6B | $19.3B | ||
| Q2 25 | $11.3B | $18.3B | ||
| Q1 25 | $11.1B | $17.6B | ||
| Q4 24 | $10.9B | $18.2B | ||
| Q3 24 | $10.6B | $18.0B | ||
| Q2 24 | $8.5B | $17.7B | ||
| Q1 24 | $8.2B | $16.1B |
负债/权益比MTDRRPRX
| Q4 25 | 0.60× | 0.92× | ||
| Q3 25 | 0.58× | 0.93× | ||
| Q2 25 | 0.61× | 0.84× | ||
| Q1 25 | 0.60× | 0.78× | ||
| Q4 24 | 0.65× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $474.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | — |
| 自由现金流率自由现金流/营收 | 1.0% | — |
| 资本支出强度资本支出/营收 | 57.6% | — |
| 现金转化率经营现金流/净利润 | 2.46× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $269.6M | — |
8季度趋势，按日历期对齐
经营现金流MTDRRPRX
| Q4 25 | $474.4M | $827.1M | ||
| Q3 25 | $721.7M | $702.6M | ||
| Q2 25 | $501.0M | $364.0M | ||
| Q1 25 | $727.9M | $596.1M | ||
| Q4 24 | $575.0M | $742.5M | ||
| Q3 24 | $610.4M | $703.6M | ||
| Q2 24 | $592.9M | $658.2M | ||
| Q1 24 | $468.6M | $664.6M |
自由现金流MTDRRPRX
| Q4 25 | $8.1M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $173.6M | — | ||
| Q4 24 | $45.2M | — | ||
| Q3 24 | $-1.6B | — | ||
| Q2 24 | $69.0M | — | ||
| Q1 24 | $-170.0M | — |
自由现金流率MTDRRPRX
| Q4 25 | 1.0% | — | ||
| Q3 25 | 8.6% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 17.3% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | -186.5% | — | ||
| Q2 24 | 8.1% | — | ||
| Q1 24 | -21.6% | — |
资本支出强度MTDRRPRX
| Q4 25 | 57.6% | — | ||
| Q3 25 | 70.3% | — | ||
| Q2 25 | 53.1% | — | ||
| Q1 25 | 55.1% | — | ||
| Q4 24 | 54.2% | — | ||
| Q3 24 | 257.4% | — | ||
| Q2 24 | 61.3% | — | ||
| Q1 24 | 81.3% | — |
现金转化率MTDRRPRX
| Q4 25 | 2.46× | 3.86× | ||
| Q3 25 | 4.09× | 2.44× | ||
| Q2 25 | 3.34× | 12.06× | ||
| Q1 25 | 3.03× | 2.50× | ||
| Q4 24 | 2.68× | 3.57× | ||
| Q3 24 | 2.46× | 1.29× | ||
| Q2 24 | 2.59× | 6.45× | ||
| Q1 24 | 2.42× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTDR
| Oil And Gas | $702.8M | 87% |
| Natural Gas Sales | $61.3M | 8% |
| Natural Gas Midstream | $45.4M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
